Case 7 — Reporting a suspected adverse reaction Clarification for “Reporting a suspected adverse reaction”: the point beginning “Record the product, t…

Case 46 — Cold-chain questions: missing records are still missing · source wording exercise Summary draft for “Cold-chain questions: missing records a…

Record dates, jurisdiction, product identification and what can actually be verified. Delivery or professional-looking packaging alone cannot establis…

Case 7 — Redacting a review: which details should stay private? Batch and product information may be relevant to a pharmacist or regulator. Decide wha…

Case 9 — Review moderation: evidence without doxxing Method note for “Review moderation: evidence without doxxing”: use “Keep original records private…

Keep three separate fields: dispatch statement, label creation if recorded, and the first physical acceptance event shown by the carrier. State the ti…

Use clear evidence-status labels and dates, and link to the underlying records. Avoid numerical trust scores or invented purchase histories; this exam…

Method note for “Delivery feedback is not a medicine-quality assessment”: use “Describe it as a delivery observation with…” as a row heading in a prop…

Limit of the answer in “Reporting a suspected adverse reaction”: “Record the product, timing and a factual description of…” is an excerpt from the dis…

Limit of the answer in “Cold-chain questions: missing records are still missing”: “It does not establish conditions…” is an excerpt from the discussio…

Case 50 — Review chronology: order date is different from delivery evidence · comparison exercise Method note for “Review chronology: order date is di…

Case 31 — Conflicting advice: identify the original source · source wording exercise Correction note for “Conflicting advice: identify the original so…

Case 51 — Review moderation: evidence without doxxing · comparison exercise Reader check for “Review moderation: evidence without doxxing”: distinguis…